CK Life Sciences International (Holdings), Inc. (0775.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap7.88B
Enterprise Value13.9B
P/E Ratio-90.3
PEG Ratio-0.75
Price/Sales Ratio1.05
Price/Book Ratio1.47
Enterprise/Revenue2.19
Enterprise/EBITDA158.78

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.01
Operating Margin-0
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue5.41B
Revenue/Share0.57
Gross Profit785.39M
EBITDA-49.42M
Net Income-188.45M
Diluted EPS-0.02

Balance Sheet

Total Cash535.66M
Total Cash/Share0.06
Total Debt6.83B
Total Debt/Equity1.73
Current Ratio0.91
Book Value Per Share0.43

Price History

52-Week Change-36.98
52-Week High1.08
52-Week Low0.53
Moving Average 50 Days0.59
Moving Average 200 Days0.74

Statistics

Average Volume3.69M
Shares Outstanding9.61B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD